| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 7e-05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |